Renal cellular response to ureteral obstruction: Role of maturation and angiotensin II

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 1 46-1, 1999, Pages

  Chevalier, Robert L ^a,b   Thornhill, Barbara A ^a   Wolstenholme, Jennifer T ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

AT2 receptor; Development; Hydronephrosis; Rat

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; LOSARTAN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; KIDNEY CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; URETER OBSTRUCTION;

EID: 0032774937     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.1.f41     Document Type: Article

References (34)

1. Chevalier, R. L., K. H. Chung, C. D. Smith, M. Ficenec, and R. A. Gomez. Renal apoptosis and clusterin following ureteral obstruction: the role of maturation. J. Urol. 156: 1474-1479, 1996.
2. Chevalier, R. L., S. Goyal, J. T. Wolstenholme, and B. A. Thornhill. Obstructive nephropathy in the neonate is attenuated by epidermal growth factor. Kidney Int. 54: 38-47, 1998.
3. Chevalier, R. L., A. Kim, B. A. Thornhill, and J. T. Wolstenholme. Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int. 55: 793-807, 1999.
4. Chevalier, R. L., C. D. Smith, J. T. Wolstenholme, S. Krajewski, and J. C. Reed. Chronic ureteral obstruction in the rat suppresses renal tubular bcl-2 and stimulates apoptosis. Exp. Nephrol. In press.
5. Chevalier, R. L., B. A. Thornhill, D. C. Belmonte, and A. J. Baertschi. Endogenous angiotensin II inhibits natriuresis following acute volume expansion in the neonatal rat. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R393-R397, 1996.
6. Chung, K. H., and R. L. Chevalier. Arrested development of the neonatal kidney following chronic ureteral obstruction. J. Urol. 155: 1139-1144, 1996.
7. 1 receptors during neonatal ureteral obstruction. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F1117-F1123, 1995.
8. Davidson, J. M., and K. N. Broadley. Manipulation of the wound-healing process with basic fibroblast growth factor. Ann. NY Acad. Sci. 638: 306, 1991.
9. Gomez, R. A. Angiotensin receptors: relevance in development and disease states. Exp. Nephrol. 2: 259-268, 1994.
10. Gomez, R. A., and V. F. Norwood. Developmental consequences of the renin-angiotensin system. Am. J. Kidney Dis. 26: 409-431, 1995.
11. Horiuchi, M., W. Hayashida, T. Kambe, T. Yamada, and V. J. Dzau. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J. Biol. Chem. 272: 19022-19026, 1997.
12. Kuizinga, M. C., J. M. Smits, J. W. Arends, and M. P. Daemen. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J. Mol. Cell. Cardiol. 30: 425-434, 1998.
13. Leri, A., P. P. Claudio, Q. Li, X. W. Wang, K. Reiss, S. G. Wang, A. Malhotra, J. Kajstura, and P. Anversa. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest. 101: 1326-1342, 1998.
14. Levy, B. I., J. Benessiano, D. Henrion, L. Caputo, C. Heymes, M. Duriez, P. Poitevin, and J. L. Samuel. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest. 98: 418-425, 1996.
15. Ma, J., H. Nishimura, A. Fogo, V. Kon, T. Inagami, and I. Ichikawa. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int. 53: 937-944, 1998.
16. Mauch, T. J., G. Yang, E. Howe, K. M. Baker, and D. E. Dostal. Determination of renin-angiotensin system component mRNA levels in developing rat kidney using multiplex polymerase chain reaction (Abstract). J. Am. Soc. Nephrol. 8: 363, 1997.
17. Nakajima, M., H. G. Hutchinson, M. Fujinaga, W. Hayashida, R. Morishita, L. Zhang, M. Horiuchi, R. E. Pratt, and V. J. Dzau. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA 92: 10663-10667, 1995.
18. Nelson, K. G., T. Takahashi, N. L. Bossert, D. K. Walmer, and J. A. McLachlan. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. USA 88: 21-25, 1991.
19. Niimura, F., P. A. Labosky, J. Kakuchi, S. Okubo, H. Yoshida, T. Oikawa, T. Ichiki, A. J. Naftilan, A. Fogo, T. Inagami, B. L. M. Hogan, and I. Ichikawa. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 96: 2947-2954, 1995.
20. Norwood, V. F., R. M. Carey, K. M. Geary, P. A. Jose, R. A. Gomez, and R. L. Chevalier. Neonatal ureteral obstruction stimulates recruitment of renin- secreting renal cortical cells. Kidney Int. 45: 1333-1339, 1994.
21. Ozono, R., Z. Q. Wang, A. F. Moore, T. Inagami, H. M. Siragy, and R. M. Carey. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
22. 1 receptor. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F989-F995, 1993.
23. Pierzchalski, P., K. Reiss, W. Cheng, C. Cirielli, J. Kajstura, J. A. Nitahara, M. Rizk, M. C. Capogrossi, and P. Anversa. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp. Cell Res. 234: 57-65, 1997.
24. Pimentel, J. L., Jr., M. Martinez-Maldonado, J. N. Wilcox, S. Wang, and C. Luo. Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int. 44: 390-400, 1993.
25. Pimentel, J. L., Jr., A. Montero, S. S. Wang, I. Yosipiv, S. El-Dahr, and M. Martinez-Maldonado. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int. 48: 1247-1253, 1995.
26. Stagner, J. I., and E. Samois. The induction of capillary bed development by endothelial cell growth factor before islet transplantation may prevent islet ischemia. Transplant. Proc. 22: 824-828, 1990.
27. Stoll, M., U. M. Steckelings, M. Paul, S. P. Bottari, R. Metzger, and T. Unger. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95: 651-657, 1995.
28. Stoneking, B. J., T. E. Hunley, H. Nishimura, J. Ma, A. Fogo, T. Inagami, M. Tamura, M. C. Adams, J. W. Brock III, and V. Kon. Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. J. Urol. 160: 1070-1074, 1998.
29. Tanaka, M., J. Ohnishi, Y. Ozawa, M. Sugimoto, S. Usuki, M. Naruse, K. Murakami, and H. Miyazaki. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem. Biophys. Res. Commun. 207: 593-598, 1995.
30. Wolf, G. Regulation of renal tubular cell growth: effects of angiotensin II. Exp. Nephrol. 2: 107-114, 1994.
31. Wong, P. C., T. B. Barnes, A. T. Chiu, D. D. Christ, J. V. Duncia, W. F. Herblin, and P. B. M. W. M. Timmermans. Losartan (DuP 753), an orally active nonpeptide angiotensin II receptor antagonist. Cardiovasc. Drugs Ther. 9: 317-339, 1991.
32. Yamada, T., M. Horiuchi, and V. J. Dzau. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA 93: 156-160, 1996.
33. 2 receptors in neonatal ureteral obstruction. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R503-R509, 1997.
34. Yoo, K. H., B. A. Thornhill, J. T. Wolstenholme, and R. L. Chevalier. Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am. J. Hypertens. 11: 715-722, 1998.